Lumivero’s Post

It takes a village, or in this case a global community effort, to make significant progress in tackling the evidence synthesis challenges we face today. This week, PICO Portal Founder Eitan Agai joined notable researchers, technologists, and guideline developers from Cochrane, JBI, The Campbell Collaboration, and others in the space at the International Collaboration for the Automation of Systematic Reviews (ICASR) Annual Meeting, to share knowledge on how we can address these challenges - setting the stage for the Global Evidence Summit which has brought together over 150 countries to discuss this important topic. #GES2024 #EvidenceSynthesis #SystematicReview

Haplogroup M Haplogroup M is significant in India for its association with mitochondrial DNA \(mtDNA\). This haplogroup is one of the most widespread and ancient haplogroups found across Asia, including in the Indian subcontinent. It plays a crucial role in tracing maternal lineage and understanding the genetic prehistory of human populations in this region. Haplogroup M is significant in India for its association with which type of genetic lineage? A\) Mitochondrial DNA B\) Y-chromosome DNA C\) Autosomal DNA D\) X-chromosome DNA Youtube video: https://lnkd.in/dy6iWthg \#nikolays_genetics_lessons

Follow the updates of the #ESMOAmbassadors and use the #ESMOBreast24 hashtag to become part of the conversation on the latest research in #BreastCancer. #bcsm

After delving into the latest insights on the labor market in Bulgaria, we would like to share the remarkable work being done by the Living Lab in Sofia! 📹 Watch the Video to hear directly from the experts about: 👉 Their local coalitions and how they’re driving community engagement. 👉 The strategic plans and expectations for future growth and innovation. 👉 The challenges they encounter and the resilience they show in overcoming them. 👉 The risks facing the ENGINE model and the proactive measures being taken. 👉 Their unique definitions of success and how they measure their impact. #SYNCLUSIVE #Innovation #LaborMarket #Bulgaria #LivingLab #Sofia #CommunityEngagement #ENGINEModel #SuccessStories

LT | Pacientams, sergantiems gerklų vėžiu, pašalinus gerklas prarandama natūralaus balso formavimo galimybė. 💬 Be to, gerklų pakaitalo – elektroninių gerklų, kurias naudoja šie pacientai – skambesys neprimena žmogaus balso, dažnai nėra tinkamai perduodamas bendraujant telefonu. Atsižvelgdami į šią problemą, #KTU ir Lietuvos sveikatos mokslų universitetas (LSMU) mokslininkai kuria specialų lietuvių kalbai pritaikytą alaringinės (begerklinės) kalbos gerinimo modelį, kuris padės pacientams atkurti bendravimo įgūdžius. EN | For laryngeal cancer patients, the removal of the larynx results in the loss of natural voice formation. 💬 In addition, the laryngeal substitute, the electronic larynx used by these patients, does not sound like a human voice and is often not properly transmitted over the phone. To address this problem, researchers at #KTU and Lithuanian University of Health Sciences are working on a special Lithuanian language-specific model to improve allaryngeal speech, which will help the patients restore their communication skills.

Great to host MP Dr Parmjeet Parmar at our Hamilton office yesterday, alongside Manaaki Whenua - Landcare Research 🤝 As a former scientist, Dr Parmar shares our passion for New Zealand tech and innovation 💡 She’s particularly focused on ensuring that the upcoming genetic modification legislation is world-class and tailored for Aotearoa. We had some insightful discussions about the future of the commercialisation sector and opportunities to grow, including: • Stabilising the commercialisation workforce 👥 • Scaling the deep tech venture pipeline 🚀 • Harmonising IP management approaches 🧩 • Doubling down on our KiwiNet mahi to deliver impact to the ecosystem 🌐 #NZTech #Collaboration #Commercialisation #DeepTech

In continuation of the Equals Role Model Campaign, this week we would like to highlight female tech startup CTO & Co-Founder at OASYS NOW Sara Okhuijsen. "Hello, I’m Sara Okhuijsen, CTO & Co-Founder of OASYS NOW. Our mission is to make precision medicine accessible for everyone. My journey began in the fascinating world of Nanobiology, where I developed a deep appreciation for the complexities of DNA and genetics. Driven by a vision to revolutionize healthcare, I focus on creating technological solutions that enhance genetic research safety and improve patient outcomes through data privacy, access and transparency. One of my core motivations is to address the alarming biases in our genetic datasets, which profoundly impact science, precision medicine, and healthcare." Find more here: https://lnkd.in/dGCQzyQV #yesdelft #womenentrepreneurs #womenempoweringwomen #RMC2024

Check out our latest interview with a EUPATI Fellow 👀 Marc van Grieken chats about his Parkinson’s diagnosis, studying to be a EUPATI Fellow during the pandemic and the incredible bond he created with his cohort despite never meeting in person ❤️ Full interview is here ▶️ https://bit.ly/3IpQ9PG #EUPATI #EUPATIFellow #FellowInFocus #Cohort4 #IAmEUPATIFellow

We are proud to welcome three young scientists with the 𝐈𝐅𝐑𝐆 𝐍𝐞𝐱𝐭𝐆𝐞𝐧 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 this year with the sponsorship of 𝘏𝘦𝘯𝘥𝘳𝘪𝘹 𝘎𝘦𝘯𝘦𝘵𝘪𝘤𝘴, 𝘗𝘰𝘶𝘭𝘵𝘳𝘺 𝘗𝘦𝘳𝘧𝘰𝘳𝘮𝘢𝘯𝘤𝘦 𝘗𝘭𝘶𝘴, 𝘢𝘯𝘥 𝘈𝘮𝘱𝘢𝘪 𝘕𝘢𝘯𝘨𝘴𝘶𝘢𝘺. Their dedication and passion for research in incubation and fertility are highly appreciated, and they bring valuable contributions to the future of the IFRG. Let's get to know the 𝐈𝐅𝐑𝐆 𝐍𝐞𝐱𝐭𝐆𝐞𝐧 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 young scientists, continuing with 𝐂𝐚𝐭𝐡𝐚𝐫𝐢𝐧𝐚 𝐁𝐫𝐨𝐞𝐤𝐦𝐞𝐮𝐥𝐞𝐧 who will give a presentation about: 𝘐𝘯𝘧𝘭𝘶𝘦𝘯𝘤𝘦 𝘰𝘧 𝘓𝘪𝘨𝘩𝘵 𝘌𝘹𝘱𝘰𝘴𝘶𝘳𝘦 𝘢𝘯𝘥 𝘌𝘢𝘳𝘭𝘺 𝘍𝘦𝘦𝘥 𝘈𝘤𝘤𝘦𝘴𝘴 𝘰𝘯 𝘵𝘩𝘦 𝘔𝘶𝘭𝘵𝘪𝘵𝘢𝘴𝘬𝘪𝘯𝘨 𝘈𝘣𝘪𝘭𝘪𝘵𝘺 𝘪𝘯 𝘓𝘢𝘺𝘪𝘯𝘨 𝘏𝘦𝘯 𝘊𝘩𝘪𝘤𝘬𝘴. Please find a short introduction of her in the attachment.

This week, we spotlight the story of Mohamed Abdelmalek, MD PhD, a winner of Seegene and Springer Nature’s jointly-held Open Innovation Program.   Mahmoud and his team explore the use of syndromic PCR testing, with its many advantages, as an alternative to traditional methods for diagnosing #UTI.   🧪 Read about Mahmoud’s experience with Seegene in the Open Innovation Program: https://bit.ly/3xJHfeh   ※ This article is branded content published in partnership with Springer Nature.   #Seegene #SpringerNature #OpenInnovationProgram #SyndromicTesting #SyndromicqPCR #UrinaryTractInfections #AWorldFreefromDiseases